UBS Downgrades Baldwin Insurance to Neutral, Lowers Price Target to $32.5
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsDowngradesPrice Target
UBS analyst Brian Meredith downgrades Baldwin Insurance (NASDAQ:BWIN) from Buy to Neutral and lowers the price target from $37 to $32.5.
UBS analyst Brian Meredith downgrades Baldwin Insurance (NASDAQ:BWIN) from Buy to Neutral and lowers the price target from $37 to $32.5.